MIR1293 (microRNA 1293)

2018-02-01  

Identity

HGNC
LOCATION
12q13.12
LOCUSID
ALIAS
MIRN1293,hsa-mir-1293,mir-1293

Other Information

Locus ID:

NCBI: 100302220
HGNC: 35286
Ensembl: ENSG00000221604
miRBase:

Variants:

dbSNP: 100302220
ClinVar: 100302220
TCGA: ENSG00000221604
COSMIC: MIR1293

RNA/Proteins

References

Pubmed IDYearTitleCitations
383674642024miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.0
383674642024miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.0
319718302020miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.5
319768302020Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.2
323206422020miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.12
319718302020miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.5
319768302020Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.2
323206422020miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.12
283382362017hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.12
283382362017hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.12

Citation

Dessen P

MIR1293 (microRNA 1293)

Atlas Genet Cytogenet Oncol Haematol. 2018-02-01

Online version: http://atlasgeneticsoncology.org/gene/57374/mir1293-(microrna-1293)